Hi Everyone,

ISMP recommends to "Embed safety strategies for potassium chloride for injection concentrate and other concentrated electrolytes such as magnesium sulfate injection..."

For our system, we've attempted to safely limit storage to emergency carts or pharmacy. However, there is a recent request to consider allowing the 50% vial to be included in a Pre-Eclampsia/Eclampsia kit in OB.

Questions:
1. Where does your system allow storage of concentrated magnesium?

Hello!

Wondering if your institutions currently stock and administer oral antidiabetic agents in the inpatient setting If so, do you have a policy or processes in place to support the safe utilization and also agents on formulary that you would be willing to share?

Related - can anyone share the alerts or safeguards that you currently have built out / in place for metformin with inpatient use? (we have Epic)

Our organization previously had not stocked or utilized oral antidiabetics - but is integrating with another health system and now looking to stock.

Good morning,

Quick question (or maybe not so quick) about where to place an IV label on IV bags, when compounding. There is several scenarios and the three I am asking about:

1) large volume IV with additive ( i.e. compound 1000 mL LR with 40 mEq KCl
2) previously batched and labeled product (i.e. Vanco 1.75 grams in 500mL NS with a compounding label on one side)
3) small volume parenteral (any compounded IV in 50 mL or 100 mL)?

Hi All,

We have furosemide on our OB/L&D override list in our Pyxis for flash pulmonary edema.
We received a request to expand furosemide override access outside of this area.

1. Do you have furosemide on your override list?
2. What is the clinical indication?

Thanks!
Liz

Good morning,

Our organization is looking at monitoring anticoagulation quality and safety measures to assess current practice and to identify CQI opportunities. What metrics does your facility currently measure (i.e.-INR, anti-XA).

Thank you!

Natalie Zilban
Medication Safety and Pharmacy Officer
Memorial Healthcare System

Hi everyone-

HNY! Is anyone compounding amoxicillin suspension in-house (inpatient or outpatient)? If so, I would love to get your recipe, etc. Thank you!

Merry Christmas and Happy New Year everyone.

I am the pharmacy director at a rural Critical Access Hospital in Northwest Ohio and am working through the new TJC standard for Antimicrobial Stewardship, MM.09.01.01 that go into effect on 1/1/2023.

I am tempted to ask a broad question about how other hospitals are meeting the new/revised EPs but will keep my questions more focused on the EPs that seem more daunting.

Hello colleagues,

Assuming you have both syringe pump and large volume pump infusion capability, what logic informs the dispensing of your neonatal/pediatric intermittent infusions?

1) Weight-based? (>10 kg, IVPB instead of a syringe)
2) Concentration/max volume-based? (>50 mL of x concentration, IVPB instead of syringe)
3) All non-adult doses administered in a syringe?
4) Other?

Thank you kindly,
Megan Fragale, PharmD, MS, BCPS
Medication Safety Officer
Skagit Regional Health

In a 30 days span we experienced multiple Alaris pump/Alaris tubing issues and wondering if anyone else is experiencing the same issue.

The issues identified were Alaris free flowing medications. This is happening mainly after the initial programming of the infusions. We did through investigation and we excluded user programming errors. We ran diagnostics and the pump doesn't even record it is free flowing. BD so far unable to replicate incidents and unable to find why.

In light of the Smith Medical urgent medical device correction letter (attached), I would like to ask what changes and/or education has your institution implemented?
Thank you,
Amirah A.
HNMC